Bharat biotech

Articles Galleries Videos
  • Bharat Biotech, Placebo-Controlled Study, phase i clinical trials of chikv vaccine underway in india bharat biotech, Bharat biotech

    Phase I Clinical Trials of CHIKV Vaccine Underway In India : Bharat Biotech 06 June 2017

    Phase I Clinical Trials of CHIKV Vaccine Underway In India : Bharat Biotech:- Indian vaccines manufacturer, Bharat Biotech announced yesterday that the phase 1 human clinical trials of the indigenously developed Chikungunya (CHIKV) vaccine is underway in India to evaluate...

    Keywords: Phase I Clinical Trials, Placebo-Controlled Study, Bharat Biotech, Phase I Clinical Trials

    Read More
    The company expects an India license for its vaccine in 2014 and World Health Organisation (WHO) prequalification in 2015 for supply to United Nations agencies, The company expects an India license for its vaccine in 2014 and World Health Organisation (WHO) prequalification in 2015 for supply to United Nations agencies, bharat biotech launch another vaccine, Bharat biotech

    Bharat Biotech launch another vaccine 06 June 2011

    HYDERABAD: Leading bio-pharma company Bharat Biotech on Monday announced that ROTAVAC®, India's first indigenously developed rotavirus diarrohea vaccine , will be sold to global public markets, UN procurement agencies and governments the world over at a price of $1. The Hyderabad-based...

    Keywords: The company expects an India license for its vaccine in 2014 and World Health Organisation (WHO) prequalification in 2015 for supply to United Nations agencies, The company expects an India license for its vaccine in 2014 and World Health Organisation (WHO) prequalification in 2015 for supply to United Nations agencies, The company expects an India license for its vaccine in 2014 and World Health Organisation (WHO) prequalification in 2015 for supply to United Nations agencies, The company expects an India license for its vaccine in 2014 and World Health Organisation (WHO) prequalification in 2015 for supply to United Nations agencies

    Read More